Moolec Science (NASDAQ:MLEC) Announces Earnings Results

Moolec Science (NASDAQ:MLEC) released its earnings results on Thursday. The company reported $47.49 earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of $2.62 million during the quarter.

Moolec Science Stock Up 13.8%

MLEC traded up $1.17 during trading on Friday, hitting $9.65. The company’s stock had a trading volume of 83,950 shares, compared to its average volume of 1,063,721. The business’s 50 day simple moving average is $8.44 and its 200-day simple moving average is $7.68. The firm has a market cap of $7.05 million, a PE ratio of -0.29 and a beta of 0.38. Moolec Science has a one year low of $3.08 and a one year high of $142.05.

Institutional Trading of Moolec Science

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC bought a new position in Moolec Science SA (NASDAQ:MLEC) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science as of its most recent filing with the SEC. Hedge funds and other institutional investors own 0.07% of the company’s stock.

Analysts Set New Price Targets

Separately, Wall Street Zen cut shares of Moolec Science from a “hold” rating to a “sell” rating in a research report on Sunday, April 26th.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.